Production (Stage)
Satellos Bioscience Inc.
MSCL.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 41.19M | 48.55M | 17.34M | 20.24M | 24.50M |
| Total Receivables | 338.00K | 435.10K | 141.40K | 733.60K | 660.90K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.84M | 1.76M | 428.60K | 372.60K | 154.30K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 700.00 | 2.20K |
| Total Current Assets | 44.37M | 50.74M | 17.91M | 21.35M | 25.31M |
|
|
|||||
| Total Current Assets | 44.37M | 50.74M | 17.91M | 21.35M | 25.31M |
| Net Property, Plant & Equipment | 3.00K | 3.50K | 12.60K | 14.60K | 14.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | 2.86M | 2.89M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 44.37M | 50.75M | 17.92M | 24.25M | 28.25M |
|
|
|||||
| Total Accounts Payable | 1.89M | 2.06M | 1.01M | 1.16M | 1.29M |
| Total Accrued Expenses | 751.00K | 1.52M | 1.67M | 1.78M | 1.48M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 63.00K | -- | -- | -- | -- |
| Total Other Current Liabilities | 63.00K | -- | -- | -- | -- |
| Total Current Liabilities | 2.70M | 3.58M | 2.68M | 2.94M | 2.77M |
|
|
|||||
| Total Current Liabilities | 2.70M | 3.58M | 2.68M | 2.94M | 2.77M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.70M | 3.58M | 2.68M | 2.94M | 2.77M |
|
|
|||||
| Common Stock & APIC | 86.48M | 80.66M | 51.81M | 50.71M | 50.72M |
| Retained Earnings | -63.24M | -52.54M | -51.44M | -44.17M | -40.18M |
| Treasury Stock & Other | 18.43M | 19.05M | 14.87M | 14.77M | 14.94M |
| Total Common Equity | 41.67M | 47.16M | 15.24M | 21.31M | 25.48M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 41.67M | 47.16M | 15.24M | 21.31M | 25.48M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 41.67M | 47.16M | 15.24M | 21.31M | 25.48M |
|
|
|||||